AbbVie submits lung cancer drug Teliso-V for FDA approval
USA—AbbVie has officially submitted a Biologics License Application (BLA) to the U.S. Food and...
Read MoreSelect Page
Oct 2, 2024
USA—AbbVie has officially submitted a Biologics License Application (BLA) to the U.S. Food and...
Read MoreOct 2, 2024
EGYPT—EL-Ezaby Pharmacy, a prominent pharmaceutical care company in Egypt, has collaborated with...
Read MoreOct 2, 2024
UAE – Neuraxpharm Group, a prominent European specialty pharmaceutical company focusing on...
Read MoreOct 2, 2024
OMAN—Dhofar Pharmaceutical Industries Company has inaugurated a state-of-the-art pharmaceutical...
Read MoreOct 2, 2024
USA—Johnson & Johnson(J&J) has announced its plan to invest of over $2 billion to...
Read MoreOct 1, 2024
FRANCE— Valerio Therapeutics S.A., a clinical-stage biotechnology company at the forefront of...
Read MoreOct 1, 2024
SWITZERLAND—Bavarian Nordic has secured a contract worth US$63 million from the U.S. government to...
Read MoreOct 1, 2024
SOUTH KOREA—SK Pharmteco, a global contract development and manufacturing organisation (CDMO), has...
Read MoreSep 30, 2024
AUSTRIA — Pharmaceutical giant Boehringer Ingelheim has inaugurated a €60 million (US$66.8...
Read MoreSep 30, 2024
USA—AstraZeneca has announced that Tagrisso (osimertinib) has been approved by the U.S. Food and...
Read More